KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Encompass Health (EHC) Divestments (2021 - 2022)

Encompass Health (EHC) has disclosed Divestments for 7 consecutive years, with $100000.0 as the latest value for Q4 2022.

For Q4 2022, Divestments rose 100.51% year-over-year to $100000.0; the TTM value through Sep 2023 reached $100000.0, up 100.43%, while the annual FY2022 figure was -$3.5 million, 97.06% up from the prior year.
Divestments hit $100000.0 in Q4 2022 for Encompass Health, up from -$100000.0 in the prior quarter.
Across five years, Divestments topped out at $100000.0 in Q4 2022 and bottomed at -$19.6 million in Q4 2021.